313 related articles for article (PubMed ID: 27933988)
21. (-)-Epigallocatechin gallate (EGCG)-nanoethosomes as a transdermal delivery system for docetaxel to treat implanted human melanoma cell tumors in mice.
Liao B; Ying H; Yu C; Fan Z; Zhang W; Shi J; Ying H; Ravichandran N; Xu Y; Yin J; Jiang Y; Du Q
Int J Pharm; 2016 Oct; 512(1):22-31. PubMed ID: 27544847
[TBL] [Abstract][Full Text] [Related]
22. Liposomal Formulations for an Efficient Encapsulation of Epigallocatechin-3-gallate: An in- Silico/Experimental Approach.
Laudadio E; Minnelli C; Amici A; Massaccesi L; Mobbili G; Galeazzi R
Molecules; 2018 Feb; 23(2):. PubMed ID: 29462955
[TBL] [Abstract][Full Text] [Related]
23. Co-encapsulation of Epigallocatechin Gallate (EGCG) and Curcumin by Two Proteins-Based Nanoparticles: Role of EGCG.
Yan X; Zhang X; McClements DJ; Zou L; Liu X; Liu F
J Agric Food Chem; 2019 Dec; 67(48):13228-13236. PubMed ID: 31610115
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic, toxicokinetic, and bioavailability studies of epigallocatechin-3-gallate loaded solid lipid nanoparticle in rat model.
Ramesh N; Mandal AKA
Drug Dev Ind Pharm; 2019 Sep; 45(9):1506-1514. PubMed ID: 31215261
[TBL] [Abstract][Full Text] [Related]
25. Comparison of antiproliferative effect of epigallocatechin gallate when loaded into cationic solid lipid nanoparticles against different cell lines.
Silva AM; Martins-Gomes C; Fangueiro JF; Andreani T; Souto EB
Pharm Dev Technol; 2019 Dec; 24(10):1243-1249. PubMed ID: 31437118
[TBL] [Abstract][Full Text] [Related]
26. Native and thermally modified protein-polyphenol coassemblies: lactoferrin-based nanoparticles and submicrometer particles as protective vehicles for (-)-epigallocatechin-3-gallate.
Yang W; Xu C; Liu F; Yuan F; Gao Y
J Agric Food Chem; 2014 Nov; 62(44):10816-27. PubMed ID: 25310084
[TBL] [Abstract][Full Text] [Related]
27. A Poloxamer-407 modified liposome encapsulating epigallocatechin-3-gallate in the presence of magnesium: Characterization and protective effect against oxidative damage.
Minnelli C; Moretti P; Fulgenzi G; Mariani P; Laudadio E; Armeni T; Galeazzi R; Mobbili G
Int J Pharm; 2018 Dec; 552(1-2):225-234. PubMed ID: 30291957
[TBL] [Abstract][Full Text] [Related]
28. Stability of (-)-epigallocatechin gallate and its activity in liquid formulations and delivery systems.
Krupkova O; Ferguson SJ; Wuertz-Kozak K
J Nutr Biochem; 2016 Nov; 37():1-12. PubMed ID: 27770867
[TBL] [Abstract][Full Text] [Related]
29. Niosomal delivery of pumpkin seed oil: development, characterisation, and physical stability.
Morakul B; Teeranachaideekul V; Buraphacheep Junyaprasert V
J Microencapsul; 2019 Mar; 36(2):120-129. PubMed ID: 30982383
[TBL] [Abstract][Full Text] [Related]
30. Antibacterial Activity of Epigallocatechin-3-gallate (EGCG) Loaded Lipid-chitosan Hybrid Nanoparticle against Planktonic Microorganisms.
Moreno APD; Marcato PD; Silva LB; Salvador SLS; Arco MCGD; Moraes JCB; Silva RSD; Rossi A
J Oleo Sci; 2024; 73(5):709-716. PubMed ID: 38692893
[TBL] [Abstract][Full Text] [Related]
31. Niosomal Nanocarriers for Enhanced Dermal Delivery of Epigallocatechin Gallate for Protection against Oxidative Stress of the Skin.
Li D; Martini N; Wu Z; Chen S; Falconer JR; Locke M; Zhang Z; Wen J
Pharmaceutics; 2022 Mar; 14(4):. PubMed ID: 35456560
[TBL] [Abstract][Full Text] [Related]
32. Fabrication of Zein-Lecithin-EGCG complex nanoparticles: Characterization, controlled release in simulated gastrointestinal digestion.
Xie H; Liu C; Gao J; Shi J; Ni F; Luo X; He Y; Ren G; Luo Z
Food Chem; 2021 Dec; 365():130542. PubMed ID: 34265644
[TBL] [Abstract][Full Text] [Related]
33. Chitosan nanoparticles enhance the plasma exposure of (-)-epigallocatechin gallate in mice through an enhancement in intestinal stability.
Dube A; Nicolazzo JA; Larson I
Eur J Pharm Sci; 2011 Oct; 44(3):422-6. PubMed ID: 21925598
[TBL] [Abstract][Full Text] [Related]
34. Nanochemoprevention by encapsulation of (-)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability.
Hu B; Ting Y; Yang X; Tang W; Zeng X; Huang Q
Chem Commun (Camb); 2012 Feb; 48(18):2421-3. PubMed ID: 22266839
[TBL] [Abstract][Full Text] [Related]
35. Cellular uptake and cytotoxicity of chitosan-caseinophosphopeptides nanocomplexes loaded with epigallocatechin gallate.
Hu B; Ting Y; Zeng X; Huang Q
Carbohydr Polym; 2012 Jun; 89(2):362-70. PubMed ID: 24750731
[TBL] [Abstract][Full Text] [Related]
36. Fabrication of chitosan-coated epigallocatechin-3-gallate (EGCG)-hordein nanoparticles and their transcellular permeability in Caco-2/HT29 cocultures.
Song H; He A; Guan X; Chen Z; Bao Y; Huang K
Int J Biol Macromol; 2022 Jan; 196():144-150. PubMed ID: 34914913
[TBL] [Abstract][Full Text] [Related]
37. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid.
Junyaprasert VB; Singhsa P; Suksiriworapong J; Chantasart D
Int J Pharm; 2012 Feb; 423(2):303-11. PubMed ID: 22155414
[TBL] [Abstract][Full Text] [Related]
38. A glycated whey protein isolate-epigallocatechin gallate nanocomplex enhances the stability of emulsion delivery of β-carotene during simulated digestion.
Wang Q; Li W; Liu P; Hu Z; Qin X; Liu G
Food Funct; 2019 Oct; 10(10):6829-6839. PubMed ID: 31578532
[TBL] [Abstract][Full Text] [Related]
39. Insight into the structural characteristics of self-assembled liposome with epigallocatechin gallate/alcohol dehydrogenase.
Zhang X; Liu L; Jiao X; Su K; Cheng W; Xu B
Colloids Surf B Biointerfaces; 2024 Jun; 238():113917. PubMed ID: 38615391
[TBL] [Abstract][Full Text] [Related]
40. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir.
Akhter S; Kushwaha S; Warsi MH; Anwar M; Ahmad MZ; Ahmad I; Talegaonkar S; Khan ZI; Khar RK; Ahmad FJ
Drug Dev Ind Pharm; 2012 Jan; 38(1):84-92. PubMed ID: 21726136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
